Publications for Dr. David Gerber

Featured Publications LegendFeatured Publications

Prevalence of Autoimmune Disease Among Patients With Lung Cancer: Implications for Immunotherapy Treatment Options.
Khan SA, Pruitt SL, Xuan L, Gerber DE JAMA Oncol 2016 Jun
Phase 1 study of romidepsin plus erlotinib in advanced non-small cell lung cancer.
Gerber DE, Boothman DA, Fattah FJ, Dong Y, Zhu H, Skelton RA, Priddy LL, Vo P, Dowell JE, Sarode V, Leff R, Meek C, Xie Y, Schiller JH Lung Cancer 2015 Oct
Effect of prior cancer on outcomes in advanced lung cancer: implications for clinical trial eligibility and accrual.
Laccetti AL, Pruitt SL, Xuan L, Halm EA, Gerber DE J. Natl. Cancer Inst. 2015 Apr 107 4
Tumor-specific targeting by Bavituximab, a phosphatidylserine-targeting monoclonal antibody with vascular targeting and immune modulating properties, in lung cancer xenografts.
Gerber DE, Hao G, Watkins L, Stafford JH, Anderson J, Holbein B, Öz OK, Mathews D, Thorpe PE, Hassan G, Kumar A, Brekken RA, Sun X Am J Nucl Med Mol Imaging 2015 5 5 493-503
Impact of prior cancer on eligibility for lung cancer clinical trials.
Gerber DE, Laccetti AL, Xuan L, Halm EA, Pruitt SL J. Natl. Cancer Inst. 2014 Nov 106 11
Stromal platelet-derived growth factor receptor a (PDGFRa) provides a therapeutic target independent of tumor cell PDGFRa expression in lung cancer xenografts.
Gerber DE, Gupta P, Dellinger MT, Toombs JE, Peyton M, Duignan I, Malaby J, Bailey T, Burns C, Brekken RA, Loizos N Mol. Cancer Ther. 2012 Nov 11 11 2473-82
Consent timing and experience: modifiable factors that may influence interest in clinical research.
Gerber DE, Rasco DW, Skinner CS, Dowell JE, Yan J, Sayne JR, Xie Y J Oncol Pract 2012 Mar 8 2 91-6
How Have We Diagnosed Early-Stage Lung Cancer without Radiographic Screening? A Contemporary Single-Center Experience.
Taiwo EO, Yorio JT, Yan J, Gerber DE PLoS ONE 2012 7 12 e52313
Phase I safety and pharmacokinetic study of bavituximab, a chimeric phosphatidylserine-targeting monoclonal antibody, in patients with advanced solid tumors.
Gerber DE, Stopeck AT, Wong L, Rosen LS, Thorpe PE, Shan JS, Ibrahim NK Clin. Cancer Res. 2011 Nov 17 21 6888-96
Lung cancer diagnostic and treatment intervals in the United States: a health care disparity?
Yorio JT, Xie Y, Yan J, Gerber DE J Thorac Oncol 2009 Nov 4 11 1322-30